SCILEX HOLDING COMPANY - COMMON STOCK

Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan

18 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)

12 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment Conference

09 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024

05 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024

30 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label

29 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain

21 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa

09 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024

01 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

24 Jul 2024 09:52:55 By Nasdaq GlobeNewswire

Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

23 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region

17 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

02 Jul 2024 16:15:30 By Nasdaq GlobeNewswire

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

02 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

01 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

20 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

14 Jun 2024 12:41:17 By Nasdaq GlobeNewswire

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

13 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

11 Jun 2024 18:20:12 By Nasdaq GlobeNewswire